Published in Antimicrob Agents Chemother on April 12, 2010
Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol Mol Biol Rev (2011) 1.90
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother (2012) 1.28
Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harb Perspect Med (2014) 1.18
Identification of a Cryptococcus neoformans cytochrome P450 lanosterol 14α-demethylase (Erg11) residue critical for differential susceptibility between fluconazole/voriconazole and itraconazole/posaconazole. Antimicrob Agents Chemother (2011) 1.16
Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients. BMC Genomics (2011) 1.06
Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010. PLoS One (2013) 1.04
Deletion of Cryptococcus neoformans AIF ortholog promotes chromosome aneuploidy and fluconazole-resistance in a metacaspase-independent manner. PLoS Pathog (2011) 1.03
Aneuploidy and drug resistance in pathogenic fungi. PLoS Pathog (2012) 0.98
Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment. Eur J Clin Microbiol Infect Dis (2013) 0.97
Azole heteroresistance in Cryptococcus neoformans: emergence of resistant clones with chromosomal disomy in the mouse brain during fluconazole treatment. Antimicrob Agents Chemother (2013) 0.95
In vitro acquisition of secondary azole resistance in Aspergillus fumigatus isolates after prolonged exposure to itraconazole: presence of heteroresistant populations. Antimicrob Agents Chemother (2011) 0.93
Characterization of the chromosome 4 genes that affect fluconazole-induced disomy formation in Cryptococcus neoformans. PLoS One (2012) 0.87
The production of reactive oxygen species is a universal action mechanism of Amphotericin B against pathogenic yeasts and contributes to the fungicidal effect of this drug. Antimicrob Agents Chemother (2014) 0.84
Identification of antifungal natural products via Saccharomyces cerevisiae bioassay: insights into macrotetrolide drug spectrum, potency and mode of action. Med Mycol (2012) 0.82
Antifungal drug susceptibility and phylogenetic diversity among Cryptococcus isolates from dogs and cats in North America. J Clin Microbiol (2014) 0.81
Rare Cryptococus gattii infection in an immunocompetent dairy goat following a cesarean section. Med Mycol Case Rep (2012) 0.81
A low-affinity penicillin-binding protein 2x variant is required for heteroresistance in Streptococcus pneumoniae. Antimicrob Agents Chemother (2014) 0.80
Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates. Front Microbiol (2016) 0.79
Synthesis and antifungal activity in vitro of isoniazid derivatives against histoplasma capsulatum var. capsulatum. Antimicrob Agents Chemother (2014) 0.79
Cryptococcus neoformans Yop1 , an endoplasmic reticulum curvature-stabilizing protein, participates with Sey1 in influencing fluconazole-induced disomy formation. FEMS Yeast Res (2012) 0.78
Antifolates inhibit Cryptococcus biofilms and enhance susceptibility of planktonic cells to amphotericin B. Eur J Clin Microbiol Infect Dis (2012) 0.77
Ploidy dynamics and evolvability in fungi. Philos Trans R Soc Lond B Biol Sci (2016) 0.77
A case report of pulmonary cryptococcosis presenting as endobronchial obstruction. J Thorac Dis (2013) 0.76
Synthesis of a New Peptide-Coumarin Conjugate: A Potential Agent against Cryptococcosis. ACS Med Chem Lett (2015) 0.76
Heteroresistance to Itraconazole Alters the Morphology and Increases the Virulence of Cryptococcus gattii. Antimicrob Agents Chemother (2015) 0.75
Molecular characterisation and antifungal susceptibility of clinical Cryptococcus deuterogattii (AFLP6/VGII) isolates from Southern Brazil. Eur J Clin Microbiol Infect Dis (2016) 0.75
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol (1982) 6.78
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Same-sex mating and the origin of the Vancouver Island Cryptococcus gattii outbreak. Nature (2005) 5.11
Aneuploidy and isochromosome formation in drug-resistant Candida albicans. Science (2006) 4.09
Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis (2000) 3.71
Natural habitat of Cryptococcus neoformans var. gattii. J Clin Microbiol (1990) 3.47
Molecular typing of IberoAmerican Cryptococcus neoformans isolates. Emerg Infect Dis (2003) 3.34
A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia (1977) 3.28
Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology (2001) 3.27
Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clin Infect Dis (1995) 3.13
Cryptococcosis. Infect Dis Clin North Am (2002) 3.01
Consensus multi-locus sequence typing scheme for Cryptococcus neoformans and Cryptococcus gattii. Med Mycol (2009) 2.80
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis (1995) 2.59
A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group. N Engl J Med (1995) 2.29
Multilocus sequence typing reveals three genetic subpopulations of Cryptococcus neoformans var. grubii (serotype A), including a unique population in Botswana. Genetics (2005) 2.16
Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR. Antimicrob Agents Chemother (1998) 2.15
Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis. Clin Infect Dis (1994) 1.87
Do major species concepts support one, two or more species within Cryptococcus neoformans? FEMS Yeast Res (2006) 1.86
Virulence, serotype, and molecular characteristics of environmental strains of Cryptococcus neoformans var. gattii. Infect Immun (1992) 1.86
Development of fluconazole resistance in Candida albicans causing disseminated infection in a patient undergoing marrow transplantation. Clin Infect Dis (1997) 1.84
Cryptococcus neoformans strains and infection in apparently immunocompetent patients, China. Emerg Infect Dis (2008) 1.72
Selection of ura5 and ura3 mutants from the two varieties of Cryptococcus neoformans on 5-fluoroorotic acid medium. J Med Vet Mycol (1992) 1.71
The hidden danger of primary fluconazole prophylaxis for patients with AIDS. Clin Infect Dis (1998) 1.60
Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans. Antimicrob Agents Chemother (2001) 1.58
In vitro antifungal susceptibility of Cryptococcus gattii. J Clin Microbiol (2004) 1.39
Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis (1996) 1.35
Heteroresistance to fluconazole in Cryptococcus neoformans is intrinsic and associated with virulence. Antimicrob Agents Chemother (2009) 1.31
Molecular epidemiology of clinical and environmental isolates of the Cryptococcus neoformans species complex reveals a high genetic diversity and the presence of the molecular type VGII mating type a in Colombia. FEMS Yeast Res (2006) 1.27
Fluconazole tolerance in clinical isolates of Cryptococcus neoformans. Antimicrob Agents Chemother (1997) 1.23
Azole drug resistance as a cause of clinical relapse in AIDS patients with cryptococcal meningitis. Int J STD AIDS (1996) 1.16
Isolation of Cryptococcus neoformans var. gattii from Eucalyptus camaldulensis in India. J Clin Microbiol (1997) 1.08
In vitro susceptibility of Cryptococcus gattii clinical isolates. Clin Microbiol Infect (2008) 1.05
Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India. J Antimicrob Chemother (2007) 0.99
A novel episomal shuttle vector for transformation of Cryptococcus neoformans with the ccdB gene as a positive selection marker in bacteria. FEMS Microbiol Lett (2000) 0.99
Identification of a novel gene, URE2, that functionally complements a urease-negative clinical strain of Cryptococcus neoformans. Microbiology (2006) 0.90
Improved diagnostic medium for separation of Cryptococcus neoformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gattii (serotypes B and C). J Clin Microbiol (1982) 6.78
A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia (1976) 6.24
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol (1984) 5.74
Melanin-lacking mutants of Cryptococcus neoformans and their virulence for mice. J Bacteriol (1982) 5.40
Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun (1986) 4.91
Taxonomic studies on Filobasidiella species and their anamorphs. Antonie Van Leeuwenhoek (1982) 4.90
Morphogenesis of Filobasidiella neoformans, the sexual state of Cryptococcus neoformans. Mycologia (1977) 4.83
Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence. Mol Cell Biol (1994) 4.22
Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol (1977) 3.91
Isolation of the URA5 gene from Cryptococcus neoformans var. neoformans and its use as a selective marker for transformation. Mol Cell Biol (1990) 3.91
Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med (1996) 3.76
Distribution of alpha and alpha mating types of Cryptococcus neoformans among natural and clinical isolates. Am J Epidemiol (1978) 3.55
A new species of Filobasidiella, the sexual state of Cryptococcus neoformans B and C serotypes. Mycologia (1977) 3.28
Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun (1982) 3.13
Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J Bacteriol (1982) 2.98
Genetic evidence for role of extracellular proteinase in virulence of Candida albicans. Infect Immun (1985) 2.91
The developmentally regulated alb1 gene of Aspergillus fumigatus: its role in modulation of conidial morphology and virulence. J Bacteriol (1998) 2.78
The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun (1996) 2.67
Chromosomal rearrangement in Candida stellatoidea results in a positive effect on phenotype. Infect Immun (1991) 2.52
Creatinine metabolism in Cryptococcus neoformans and Cryptococcus bacillisporus. J Bacteriol (1980) 2.52
A developmentally regulated gene cluster involved in conidial pigment biosynthesis in Aspergillus fumigatus. J Bacteriol (1999) 2.50
Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect Immun (1992) 2.32
Deletion of the Candida glabrata ERG3 and ERG11 genes: effect on cell viability, cell growth, sterol composition, and antifungal susceptibility. Antimicrob Agents Chemother (1995) 2.32
Restriction fragment polymorphism in mitochondrial DNA of Cryptococcus neoformans. J Gen Microbiol (1989) 2.28
Comparison of the electrophoretic karyotypes and chromosomal location of ten genes in the two varieties of Cryptococcus neoformans. Microbiology (1994) 2.14
DNA probe for strain typing of Cryptococcus neoformans. J Clin Microbiol (1992) 2.12
Isolation of the third capsule-associated gene, CAP60, required for virulence in Cryptococcus neoformans. Infect Immun (1998) 2.10
Studies on Emmonsiella capsulata (Histoplasma capsulatum). II. Distribution of the two mating types in 13 endemic states of the United States. Am J Epidemiol (1974) 2.06
New, special stain for histopathological diagnosis of cryptococcosis. J Clin Microbiol (1981) 2.04
Aspergillus nidulans infection in chronic granulomatous disease. Medicine (Baltimore) (1998) 2.03
IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma. J Immunol (1995) 1.94
Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections. Clin Infect Dis (1992) 1.84
Concentrations of airborne Aspergillus compared to the incidence of invasive aspergillosis: lack of correlation. Med Mycol (1998) 1.83
Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia (1978) 1.83
Isolation, characterization, and localization of a capsule-associated gene, CAP10, of Cryptococcus neoformans. J Bacteriol (1999) 1.79
Physical and genetic mapping of Candida albicans: several genes previously assigned to chromosome 1 map to chromosome R, the rDNA-containing linkage group. Infect Immun (1991) 1.79
Rapid method to extract DNA from Cryptococcus neoformans. J Clin Microbiol (1991) 1.78
Candida albicans in patients with the acquired immunodeficiency syndrome: absence of a novel of hypervirulent strain. J Infect Dis (1990) 1.77
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Structural studies on the major, capsular polysaccharide from Cryptococcus bacillisporus serotype B. Carbohydr Res (1980) 1.74
Melanogenesis in Cryptococcus neoformans. J Gen Microbiol (1988) 1.73
Cryptococcus neoformans STE12alpha regulates virulence but is not essential for mating. J Exp Med (2000) 1.71
High prevalence of Cryptococcus neoformans var. gattii in tropical and subtropical regions. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 1.68
Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species. J Med Vet Mycol (1996) 1.67
On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype C. Immunochemistry (1978) 1.66
Cryptococcus neoformans CAP59 (or Cap59p) is involved in the extracellular trafficking of capsular glucuronoxylomannan. Eukaryot Cell (2004) 1.64
On the origins of congenic MATalpha and MATa strains of the pathogenic yeast Cryptococcus neoformans. Fungal Genet Biol (1999) 1.60
Cryptococcus neoformans induces alterations in the cytoskeleton of human brain microvascular endothelial cells. J Med Microbiol (2003) 1.59
Production and regeneration of protoplasts from Cryptococcus. Sabouraudia (1985) 1.59
Diversity of DNA fingerprints in Cryptococcus neoformans. J Clin Microbiol (1995) 1.50
Capsular polysaccharides from a parent strain and from a possible, mutant strain of Cryptococcus neoformans serotype A. Carbohydr Res (1981) 1.48
Studies on Emmonsiella capsulata. I. Heterothallism and development of the ascocarp. Mycologia (1973) 1.41
The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D. Carbohydr Res (1979) 1.41
Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob Agents Chemother (1999) 1.38
Chronic cystitis due to Cokeromyces recurvatus: a case report. J Infect Dis (1987) 1.36
Structural variability in the glucuronoxylomannan of Cryptococcus neoformans serotype A isolates determined by 13C NMR spectroscopy. Carbohydr Res (1992) 1.34
Virulence of catalase-deficient aspergillus nidulans in p47(phox)-/- mice. Implications for fungal pathogenicity and host defense in chronic granulomatous disease. J Clin Invest (1998) 1.33
Agrobacterium tumefaciens-mediated transformation of Aspergillus fumigatus: an efficient tool for insertional mutagenesis and targeted gene disruption. Appl Environ Microbiol (2005) 1.33
Aspergillus fumigatus arp1 modulates conidial pigmentation and complement deposition. Mol Microbiol (1997) 1.32
Nuclear genotypes of spore chains in Filobasidiella neoformans (Cryptococcus neoformans). Mycologia (1980) 1.30
Comparative study of an isolate resembling Banti's fungus with Cladosporium trichoides. Sabouraudia (1983) 1.30
Sexual stage of Histoplasma capsulatum. Science (1972) 1.28
Isolation and characterization of cell surface mutants of Candida albicans. Infect Immun (1990) 1.27
Pentaketide melanin biosynthesis in Aspergillus fumigatus requires chain-length shortening of a heptaketide precursor. J Biol Chem (2001) 1.25
On the structure of the capsular polysaccharide from Cryptococcus neoformans serotype C--II. Mol Immunol (1979) 1.24
Mapping of the Cryptococcus neoformans MATalpha locus: presence of mating type-specific mitogen-activated protein kinase cascade homologs. J Bacteriol (2000) 1.24
Neosartorya udagawae (Aspergillus udagawae), an emerging agent of aspergillosis: how different is it from Aspergillus fumigatus? J Clin Microbiol (2009) 1.23
Ultrastructure of septal complex in Filobasidiella neoformans (Cryptococcus neoformans). J Bacteriol (1976) 1.23
Comparison of isolates of Sporothrix schenckii obtained from fixed cutaneous lesions with isolates from other types of lesions. J Infect Dis (1979) 1.23
Hydrolytic polyketide shortening by ayg1p, a novel enzyme involved in fungal melanin biosynthesis. J Biol Chem (2004) 1.23
Uniqueness of the mating system in Cryptococcus neoformans. Trends Microbiol (2004) 1.22
Genetic complementation in Cryptococcus neoformans. J Bacteriol (1986) 1.20
The second STE12 homologue of Cryptococcus neoformans is MATa-specific and plays an important role in virulence. Proc Natl Acad Sci U S A (2001) 1.19
Complementation analysis of resistance to 5-fluorocytosine in Candida albicans. Antimicrob Agents Chemother (1986) 1.18
HYP1, a hydrophobin gene from Aspergillus fumigatus, complements the rodletless phenotype in Aspergillus nidulans. Infect Immun (1994) 1.16
A gene homologous to Saccharomyces cerevisiae SNF1 appears to be essential for the viability of Candida albicans. Infect Immun (1997) 1.15
Distribution of the two mating types among Histoplasma capsulatum isolates obtained from an urban histoplasmosis outbreak. Sabouraudia (1984) 1.14
Cryptococcus neoformans: virulence and host defences. Med Mycol (1998) 1.12
CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans. Infect Immun (2006) 1.12
Formation of a minichromosome in Cryptococcus neoformans as a result of electroporative transformation. Curr Genet (1994) 1.12
Disseminated Phialophora parasitica infection in humans: case report and review. Rev Infect Dis (1989) 1.11
THTA, a thermotolerance gene of Aspergillus fumigatus. Fungal Genet Biol (2004) 1.10
Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease. Clin Infect Dis (1992) 1.10
Mycotic granuloma caused by Phialophora repens. Am J Clin Pathol (1975) 1.10
The major capsular polysaccharide of Cryptococcus neoformans serotype B. Carbohydr Res (1992) 1.09
Gymnoascus demonbreunii Ajello & Cheng evidence that it is not the perfect state of Histoplasma capsulatum Darling. Sabouraudia (1968) 1.08
Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy. Carbohydr Res (1996) 1.07
A second heterothallic Aspergillus. Mycologia (1974) 1.06
Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia. Am J Clin Pathol (1975) 1.05
Aspergillus quadrilineatus, a new causative agent of fungal sinusitis. J Clin Microbiol (1992) 1.05
High frequency transformation of Cryptococcus neoformans and Cryptococcus gattii by Agrobacterium tumefaciens. Fungal Genet Biol (2005) 1.04
Parasexual genetics of Torulopsis glabrata. J Bacteriol (1987) 1.04
Subcutaneous abscess caused by Phoma sp. resembling Pyrenochaeta romeroi: unique fungal infection occurring in immunosuppressed recipient of renal allograft. Am J Clin Pathol (1973) 1.04
Cyclosporin immunosuppression as the possible cause of AIDS. N Engl J Med (1983) 1.03
Emmonsiella capsulata: perfect state of Histoplasma capsulatum. Science (1972) 1.03
The molecular analysis of synonymy among medically important yeasts within the genus Candida. J Gen Microbiol (1992) 1.03
A survey of heterobasidiomycetous yeasts for the presence of the genes homologous to virulence factors of Filobasidiella neoformans, CNLAC1 and CAP59. Microbiology (2001) 1.02
Chronic granulomatous disease of childhood. An unusual case of infection with Aspergillus nidulans var. echinulatus. Am J Clin Pathol (1988) 1.02